Why Eli Lilly Stock Is Rising Today
Eli Lilly And Co (NYSE: LLY) shares are trading higher Tuesday following positive analyst coverage from BMO Capital.
This Analyst Predicts $396 For Eli Lilly, Plus Raymond James Slashes PT On This Stock By Over 73%
Raymond James cut the price target for PolyPid Ltd. (NASDAQ: PYPD) from $15 to $4. PolyPid shares fell 7.7% to $1.32 in pre-market trading.
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back…
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 10 years by 10.14% on an annualized basis producing an average annual return of 21.08%. Currently, Eli Lilly has a market capitalization of $291.57 billion.
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion).
Eli Lilly Whale Trades For August 18
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly.
Looking at options history for Eli Lilly (NYSE:LLY) we detected 15 strange trades.
Weekend Stock Spotlight: Affirm, SoftBank And How Trump Documents Seizure May Impact Midterms
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read.
Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug…
This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing
ProQR Therapeutics N.V. (NASDAQ:PRQR) said it would look for a partner to take the company’s ophthalmology portfolio further into clinical trials. …
Eli Lilly Whale Trades For August 11
Someone with a lot of money to spend has taken a bearish stance on Eli Lilly (NYSE:LLY).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.